It wouldn't be a capital loss - I think Seymour bought most of those shares when the price dipped in December, so 17c+ is a profit...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025